OraSure Technologies, Inc. Applauds New Centers for Disease Control and Prevention (CDC) Recommendations That All Baby Boomers be Tested for Hepatitis C

Published: Aug 16, 2012

BETHLEHEM, Pa., Aug. 16, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, today announced its enthusiastic support for the expanded hepatitis C testing recommendations issued by the Centers for Disease Control and Prevention (CDC), urging that all U.S. baby boomers get a one-time test for the hepatitis C virus (HCV).

Back to news